PL3288965T3 - Rozpuszczalny chimeryczny receptor interleukiny-10 i jego zastosowanie terapeutyczne - Google Patents

Rozpuszczalny chimeryczny receptor interleukiny-10 i jego zastosowanie terapeutyczne

Info

Publication number: PL3288965T3
Authority: PL; Poland
Prior art keywords: receptor; therapeutic use; soluble chimeric; chimeric interleukin; interleukin
Prior art date: 2015-04-29

Application number

PL16728097T

Other languages

English (en)

Inventor

Gilberto Filaci

Daniela Fenoglio

Francesca Ferrera

Original Assignee

Mediolanum Farm S P A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-04-29

Filing date

2016-04-26

Publication date

2019-11-29

2016-04-26 Application filed by Mediolanum Farm S P A filed Critical Mediolanum Farm S P A

2019-11-29 Publication of PL3288965T3 publication Critical patent/PL3288965T3/pl

Links

102000004551 Interleukin-10 Receptors Human genes 0.000 title 1
108010017550 Interleukin-10 Receptors Proteins 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
- C07K2317/53—Hinge
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Epidemiology (AREA)

PL16728097T 2015-04-29 2016-04-26 Rozpuszczalny chimeryczny receptor interleukiny-10 i jego zastosowanie terapeutyczne PL3288965T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
ITUB20150391		2015-04-29
PCT/IB2016/052359 WO2016174575A1 (en)	2015-04-29	2016-04-26	A soluble chimeric interleukin-10 receptor and therapeutic use thereof
EP16728097.3A EP3288965B1 (en)	2015-04-29	2016-04-26	A soluble chimeric interleukin-10 receptor and therapeutic use thereof

Publications (1)

Publication Number	Publication Date
PL3288965T3 true PL3288965T3 (pl)	2019-11-29

Family

ID=53765409

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL16728097T PL3288965T3 (pl)	2015-04-29	2016-04-26	Rozpuszczalny chimeryczny receptor interleukiny-10 i jego zastosowanie terapeutyczne

Country Status (16)

Country	Link
US (1)	US20180086809A1 (pl)
EP (1)	EP3288965B1 (pl)
JP (1)	JP2018518945A (pl)
KR (1)	KR20170138569A (pl)
CN (1)	CN107531771A (pl)
CA (1)	CA2979973A1 (pl)
CY (1)	CY1122061T1 (pl)
DK (1)	DK3288965T3 (pl)
ES (1)	ES2744342T3 (pl)
HK (1)	HK1245814B (pl)
HU (1)	HUE046343T2 (pl)
PL (1)	PL3288965T3 (pl)
PT (1)	PT3288965T (pl)
SI (1)	SI3288965T1 (pl)
SM (1)	SMT201900530T1 (pl)
WO (1)	WO2016174575A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2017336546C1 (en)	2016-09-27	2025-05-29	Epicentrx, Inc.	Immunomodulatory fusion proteins
KR102757384B1 (ko) *	2017-09-27	2025-01-20	에피센트알엑스, 인코포레이티드	면역조절 융합 단백질
CN121971599A (zh)	2019-02-25	2026-05-05	芝加哥大学	用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
WO2021185824A1 (en) *	2020-03-16	2021-09-23	Vrije Universiteit Brussel	A mixture of mrna to enhance the potency of dendritic cells
CN116162149A (zh) *	2022-12-06	2023-05-26	苏州绶草生物科技有限公司	一种提高植物中合成重组人血清白蛋白基因表达量的方法
CN116125074A (zh) *	2022-12-13	2023-05-16	北京东方百泰生物科技股份有限公司	一种IL-10-Fc融合蛋白与其受体结合活性的检测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5789192A (en) *	1992-12-10	1998-08-04	Schering Corporation	Mammalian receptors for interleukin-10 (IL-10)
US6165476A (en) *	1997-07-10	2000-12-26	Beth Israel Deaconess Medical Center	Fusion proteins with an immunoglobulin hinge region linker
EP1274720A4 (en) *	2000-04-12	2004-08-18	Human Genome Sciences Inc	FUSION PROTEINS CONTAINING ALBUMIN
JP4635255B2 (ja) *	2003-09-02	2011-02-23	独立行政法人産業技術総合研究所	抗体医薬
WO2005047337A1 (en) *	2003-11-13	2005-05-26	Hanmi Pharmaceutical Co., Ltd.	A pharmaceutical composition comprising an immunoglobulin fc region as a carrier
KR100897938B1 (ko) *	2007-05-30	2009-05-18	주식회사 제넥신	면역글로불린 융합 단백질
EP3281955A1 (en) *	2008-10-02	2018-02-14	Aptevo Research and Development LLC	Cd86 antagonist multi-target binding proteins
BR112014029409B1 (pt) *	2012-05-25	2022-11-29	Janssen Biotech, Inc	Domínio de ligação a albumina isolado não natural, método para produção do mesmo, polinucleotídeo isolado, vetor isolado, célula hospedeira isolada, proteína de fusão e composição farmacêutica

2016
- 2016-04-26 PL PL16728097T patent/PL3288965T3/pl unknown
- 2016-04-26 ES ES16728097T patent/ES2744342T3/es active Active
- 2016-04-26 PT PT167280973T patent/PT3288965T/pt unknown
- 2016-04-26 US US15/562,557 patent/US20180086809A1/en not_active Abandoned
- 2016-04-26 CA CA2979973A patent/CA2979973A1/en not_active Abandoned
- 2016-04-26 CN CN201680024854.0A patent/CN107531771A/zh active Pending
- 2016-04-26 KR KR1020177034625A patent/KR20170138569A/ko not_active Withdrawn
- 2016-04-26 HK HK18105461.9A patent/HK1245814B/en not_active IP Right Cessation
- 2016-04-26 WO PCT/IB2016/052359 patent/WO2016174575A1/en not_active Ceased
- 2016-04-26 EP EP16728097.3A patent/EP3288965B1/en active Active
- 2016-04-26 SI SI201630348T patent/SI3288965T1/sl unknown
- 2016-04-26 JP JP2017556722A patent/JP2018518945A/ja active Pending
- 2016-04-26 SM SM20190530T patent/SMT201900530T1/it unknown
- 2016-04-26 HU HUE16728097A patent/HUE046343T2/hu unknown
- 2016-04-26 DK DK16728097.3T patent/DK3288965T3/da active
2019
- 2019-09-23 CY CY20191100997T patent/CY1122061T1/el unknown

Also Published As

Publication number	Publication date
US20180086809A1 (en)	2018-03-29
PT3288965T (pt)	2019-10-15
CA2979973A1 (en)	2016-11-03
HK1245814B (en)	2020-06-19
CN107531771A (zh)	2018-01-02
EP3288965B1 (en)	2019-06-26
ES2744342T3 (es)	2020-02-24
CY1122061T1 (el)	2020-11-25
DK3288965T3 (da)	2019-09-23
KR20170138569A (ko)	2017-12-15
WO2016174575A1 (en)	2016-11-03
JP2018518945A (ja)	2018-07-19
SMT201900530T1 (it)	2019-11-13
HUE046343T2 (hu)	2020-02-28
EP3288965A1 (en)	2018-03-07
SI3288965T1 (sl)	2019-10-30

Publication	Publication Date	Title
IL250685A0 (en)	2017-04-30	Medicinal substance induces cytotoxicity
GB201403093D0 (en)	2014-04-09	Therapeutic compounds and their use
PL3132034T3 (pl)	2021-04-06	Środek terapeutyczny
IL247072A0 (en)	2016-09-29	Medical use
SG10201912792YA (en)	2020-02-27	Therapeutic compounds and methods
IL250990A0 (en)	2017-04-30	Materials for human care
GB201410216D0 (en)	2014-07-23	Therapeutic
SMT201900530T1 (it)	2019-11-13	Recettore chimerico solubile dell'interleuchina 10 e relativo impiego terapeutico
GB201502412D0 (en)	2015-04-01	Therapeutic use
GB201720992D0 (en)	2018-01-31	A medical use
GB201608797D0 (en)	2016-07-06	Therapeutic use
GB201700526D0 (en)	2017-03-01	Therapeutic use
GB201510637D0 (en)	2015-07-29	Therapeutic
GB201506786D0 (en)	2015-06-03	Therapeutic use
GB2568266B (en)	2022-06-22	Therapeutic device
GB2554997B (en)	2021-01-13	A therapeutic bed
IL232605A0 (en)	2014-08-31	Flexible joint device
GB201410334D0 (en)	2014-07-23	Therapeutic
ZA201703580B (en)	2018-08-29	Therapeutic homodimer and uses thereof
AU201713986S (en)	2017-09-12	Patient interface
AU201712841S (en)	2017-07-14	Patient interface
AU201711184S (en)	2017-05-15	Patient interface
GB201516494D0 (en)	2015-11-04	New therapeutic use
GB201415302D0 (en)	2014-10-15	New therapeutic use
GB201410387D0 (en)	2014-07-23	Compounds and their therapeutic use